Close Menu

NEW YORK — Trinity Biotech today reported total revenues for the third quarter increased 4 percent year over year boosted by a 29 percent jump in point-of-care revenues.

For the three months ended Sept. 30, the Dublin-based diagnostics firm posted $24.6 million in total revenues, up from $23.7 million in Q3 2018.

Point-of-care revenues grew to $3.9 million from $3.0 million a year ago, while clinical laboratory product revenues were flat at $20.7 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.